Clinical Trial Update: Circulating Tumor DNA MRD-Guided Adjuvant Therapy for Curatively Resected Locally Advanced Esophageal Squamous Cell Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating circulating tumor DNA MRD-guided adjuvant therapy after curative resection of locally advanced esophageal squamous cell carcin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Snippet

Sponsor: Asan Medical Center | Conditions: Esophageal Cancer | Phase 3 | Status: NOT_YET_RECRUITING